Boehringer Ingelheim · 11 hours ago
Scientist II/III, New Biological Entities PK/BA Group
Boehringer Ingelheim is seeking a highly motivated Scientist II/III to join the NBE Bioanalytical (BA) group in the global Drug Discovery Sciences (DDS) department. The successful candidate will design and implement non-regulated custom quantitative pharmacokinetic and biomarker ligand binding assays, collaborating with stakeholders to enhance bioanalytical capabilities.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Independently develops and implements custom quantitative ligand binding assays, e.g., ELISA, MSD, Quanterix and/or Gyros to measure antibodies, protein therapeutics and biomarkers in biological matrices
Troubleshoots effectively and solves scientific problems independently; Operates lab equipment and is independently responsible for maintenance
Designs and executes non-routine experiments on a basis of literature analyses with minimal supervision
Independently applies basic scientific principles, performs literature searches, attends scientific meetings, and keeps abreast of literature in own field
Proposes new experiments/technologies based on science as well as overall understanding of drug discovery/development process; Demonstrates expertise in field and contributes to training technicians and junior level scientists
Effectively communicates and defends own work in the context of team and department goals both orally and in writing
Reports and treats data with a high level of integrity and ethics; Writes protocols, procedures, and technical reports; Provides input for scientific reports
Complies with applicable regulations, performing all work in a safe manner; Maintains proper records in accordance with SOPs and policies
Qualification
Required
Master's degree in biology, biochemistry, immunology, physiology, chemistry, pharmacy or related field with relevant experience in laboratory research in the pharmaceutical and/or biotech industry or Bachelor's degree in biology, biochemistry, immunology, physiology, chemistry, pharmacy or related field with 3+ years of relevant experience in laboratory research in the pharmaceutical and/or biotech industry
Experience developing custom quantitative ligand binding assays, e.g., ELISA, MSD, Quanterix and/or Gyros to measure antibodies and proteins in various matrices desirable
Master's degree in biology, biochemistry, immunology, physiology, chemistry, pharmacy or related field with 6 years of experience in laboratory research in the pharmaceutical and/or biotech industry
Proficient in developing custom quantitative ligand binding assays, e.g., ELISA, MSD, Quanterix and/or Gyros to measure antibodies and proteins in various matrices
High technical proficiency/attention to detail, with strong problem-solving skills and ability to adapt to evolving technologies
Ability to build effective working relationships and aptitude for sharing expertise with cross-functional and global teams
Ability to communicate effectively both orally and in writing in an interdisciplinary environment
Must be legally authorized to work in the United States
Must be willing to submit to a background investigation, including verification of your past employment, criminal history, and educational background
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older
Benefits
Role specific variable or performance based bonus
Other compensation elements
Company
Boehringer Ingelheim
Boehringer Ingelheim is a group of pharmaceutical companies that focuses on prescription medicines and animal health. It is a sub-organization of Boehringer Ingelheim.
H1B Sponsorship
Boehringer Ingelheim has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (4)
2023 (11)
2022 (7)
2021 (17)
2020 (1)
Funding
Current Stage
Late StageLeadership Team
Recent News
BioWorld Financial Watch
2026-02-02
Mexico Business
2026-02-02
Company data provided by crunchbase